Clinical expertise with blood vessel administration of antioxidant http://www.theelixirclinic.com
Background
• Ascorbic acid (vitamin C, ascorbate) could be a key water soluble inhibitor that, once administered in doses well on top of its suggested dietary allowance, could have preventative and therapeutic worth against variety of pathologies
Methods • Medical records of patients with cancer treated with IVC at the Riordan Clinic were retrospectively reviewed
Results • The results of the analysis can be summarized as follows • IVC produces peak plasma ascorbate concentrations on the order of 10 millimolars with lower peak plasma concentrations obtained in cancer patients as compared to healthy subjects • Cancer patients WHO square measure deficient in vitamin C before medical aid tend to attain lower plasma levels post infusion
Conclusions • The data indicates that, whereas probably therapeutic plasma ascorbate concentrations is achieved with IVC, levels earned can vary supported tumour burden and degree of inflammation (among alternative factors) • Find out more at US National Library of Medicine-National Institute of H ealth